ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Bruker Demonstrates Novel and Unique Compact 1.0 GHz NMR Magnet

New Innovations Support Customers to Reduce Liquid Helium Consumption

At the Experimental Nuclear Magnetic Resonance Conference (ENC 2022), Bruker demonstrates a novel and remarkably compact 1.0 GHz NMR magnet, operating at 4.2 Kelvin, for structural biology applications in single-story standard laboratories. Bruker also offers innovations and services for reducing liquid helium consumption.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220425005204/en/

Unique compact Bruker Ascend Evo 1.0 GHz magnet offers significantly reduced footprint, weight, and ceiling height requirements, as well as a dramatic threefold reduction in liquid helium consumption (Photo: Business Wire)

Unique compact Bruker Ascend Evo 1.0 GHz magnet offers significantly reduced footprint, weight, and ceiling height requirements, as well as a dramatic threefold reduction in liquid helium consumption (Photo: Business Wire)

A major innovation and technology introduction from Bruker is the recent successful factory energization and protein NMR testing of a unique single-story 1.0 GHz 4K NMR magnet, called Ascend Evo 1.0 GHz. Its significantly reduced footprint, weight, and ceiling height requirements, as well as a dramatic threefold reduction in liquid helium consumption provides many more structural biology researchers access to the sensitivity and resolution of GHz NMR. At ENC, Bruker is showing excellent protein 1.0 GHz NMR data from this new and unique technological marvel.

A second innovation is the limited release of the new Heliosmart Recovery solution, a compact, easy-to-site system that can be retrofitted to collect helium gas boil-off from installed NMR magnets. The helium gas is stored in high-pressure cylinders in support of a circular helium economy. The Heliosmart Recovery system can collect the normal boil-off of several NMR magnets, resulting in typical steady-state recovery rates of 80% – 85%. The recovered high-pressure helium gas can be utilized at local or regional helium reliquefaction facilities.

Bruker offers free LabScape Remote Monitoring, which enables our experts to proactively monitor magnets and identify upcoming cryogen refills that can be scheduled well in advance. Bruker also offers helium refills as a service with selected NMR maintenance service agreements.

Dr. Falko Busse, President of the Bruker BioSpin Group, commented: “We are extremely pleased to demonstrate the world’s first single-story 1.0 GHz standard-bore 4 Kelvin NMR magnet, and we are committed to reducing the consumption of liquid helium with our latest innovations.”

About Bruker Corporation (Nasdaq: BRKR)

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular and cell biology research, in applied and pharma applications, in microscopy and nanoanalysis, as well as in industrial applications. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit: www.bruker.com.

Contacts

Investor Contact:

Justin Ward

Sr. Director, Investor Relations & Corporate Development

T: +1 (978) 663-3660 x1479

E: Investor.Relations@bruker.com



Media Contact:

Thorsten Thiel, Ph. D.

VP of Group Marketing, Bruker BioSpin

T: +49 (721) 5161–6500

E: pr@bruker.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.